Anat Stemmer‐Rachamimov

Massachusetts General Hospital — United States

Medicine · Health Sciences

70h-index24.5kcitations391works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurofibromatosis and Schwannoma Cases(163), Meningioma and schwannoma management(86), Neuroblastoma Research and Treatments(50), Glioma Diagnosis and Treatment(45), Virus-based gene therapy research(26)

Publications380 total

Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated Pain.
PubMed·2026
Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases
Neuro-Oncology·2026
Immunohistopathology of Cochleovestibular Schwannoma in Human Temporal Bone Specimens
Biology·2025· 1 citedOpen Access
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas
PMC·2025Open Access
P14.18.A SCHWANNOMAS DISPLAY CONSERVED CELLULAR STATES AND PREFERENTIAL MHC CLASS II ANTIGEN PRESENTATION ACROSS DIFFERENT GENETIC BACKGROUNDS AND ANATOMIC LOCATIONS
Neuro-Oncology·2025Open Access
AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1
Molecular Therapy — Methods & Clinical Development·2025Open Access
Increased Hemorrhage During Excision of Bevacizumab‐Treated <scp>NF2</scp> ‐Related Vestibular Schwannomas
The Laryngoscope·2025· 2 cited
Engineered AAV capsids mediate transduction of murine neurofibroma and sciatic nerve
Gene Therapy·2025
Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patients
Brain Pathology·2025Open Access
A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations
Genome Medicine·2025· 2 citedOpen Access
Non-<i>NF2</i>-related schwannomatosis and rhabdoid tumor predisposition syndrome
2025
Neurofibromatosis 1
2025
<i>NF2</i>-related schwannomatosis (formerly known as neurofibromatosis type 2)
2025
1051 Blood-Based Diagnosis, Prognostication, and Monitoring of IDH Mutant Gliomas
Neurosurgery·2025
1506 Ocular Ubiquitin Inclusions in Fragile X-Associated Tremor Ataxia Syndrome: A Novel Finding
Laboratory Investigation·2025
Breast Cancer‐Derived Extracellular Vesicles Modulate the Cytoplasmic and Cytoskeletal Dynamics of Blood‐Brain Barrier Endothelial Cells
Journal of Extracellular Vesicles·2025· 10 citedOpen Access
Immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypes
Neuro-Oncology Advances·2024Open Access
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1
Neuro-Oncology·2024· 15 citedOpen Access
PATH-25. CONSENSUS RECOMMENDATIONS FOR AN INTEGRATED DIAGNOSTIC APPROACH TO NERVE SHEATH TUMORS ARISING IN THE SETTING OF NEUROFIBROMATOSIS TYPE 1
Neuro-Oncology·2024Open Access
Reply to L. Lucchino et al. on commentary on “Histologic correlates of “Choroidal Abnormalities” in Neurofibromatosis type 1”
Acta Neuropathologica·2024
page 1 of 19Next →

Frequent Co-authors

Scott R. Plotkin(11), David N. Louis(9), William T. Curry(6), Fred G. Barker(6), Marco Giovannini(6), Gad Getz(5), Jaishri O. Blakeley(5), Bruce R. Korf(5), Mia MacCollin(5), D. Gareth Evans(5), Tracy T. Batchelor(4), Michal Barzily-Rokni(4), Jean-Pierre Eliane(4), Marc R. Hammond(4), Hans Vitzthum(4), Keith T. Flaherty(4), Genevieve M. Boland(4), Sandro Santagata(4), Rameen Beroukhim(4), Ludwine Messiaen(4)